Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent ...
The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the ...
If proven effective in humans, the vaccine could complement standard therapies for HPV-driven cancer, as well as inform the ...
In this week’s edition of InnovationRx, we look at the healthcare giants on Forbes new Greatest Innovators list, why Garner ...
The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu ...
Rare but dangerous blood clotting associated with that vaccine as well as AstraZeneca’s had a genetic cause, according to a new paper.
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...
Despite receiving pushback from host Dana Bash, Oz held firm, saying Kennedy made comments in support of the MMR shot when a ...
Moderna claimed that the decision, issued by top vaccine regulator Vinay Prasad, was “inconsistent” with prior FDA ...
By Sneha S K Feb 10 (Reuters) - The U.S. Food and Drug Administration will not review Moderna's approval application for its ...
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
FDA refuses Moderna's mRNA flu vaccine application, citing inadequate study design, as the company disputes decision, saying it contradicts prior FDA guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results